검색어: c‑reactive protein increased (영어 - 몰타어)

c-reactive protein increased
Żieda fi proteina reattiva Ċ

c-reactive protein
proteina reattiva Ċ

c-reactive protein increased blood calcium decreased
Żieda fil-proteina reattiva c tnaqqis tal-kalċju fid-demm

increased c-reactive protein
Żieda fil-proteina c- reattiva

c-reactive protein increased, blood parathyroid hormone increased
żieda fil-proteina Ċ-reattiva, żieda fl-ormon tal-paratirojde fid-demm,

investigations increased c-reactive protein
investigazzjonijiet żieda fil-proteina Ċ reattiva

rare semen analysis abnormal, c-reactive protein increased, blood calcium decreased
analiżi tas-semen mhux normali, żieda fil-proteina reattiva Ċ, tnaqqis tal-kalċju fid-demm

increased protein (c-reactive protein) in blood indicating inflammation
Żieda fil-proteini (proteina ċ-reattiva) fid-demm li tindika infjammazzjoni

hyperbilirubinaemia*, protein analyses abnormal*, weight increased, blood test abnormal*, c-reactive protein increased
iperbilirubinemija*, valuri anormali tal-analiżi ta’ proteini*, Żieda fil-piż, valuri anormali tat-testijiet tad- demm*, Żieda fil-proteina li tirreaġixxi ma’ c

increased level of c-reactive protein, which can be seen in results of blood tests
livell ogħla ta’ proteina reattiva Ċ, li jista’ jidher fir-riżultati tat-testijiet tad-demm

high blood sugar (hyperglycaemia), increased salt, urea, creatinine and potassium in your blood blood test result indicating inflammation (c-reactive protein increased)
livell għoli ta’ zokkor fid-demm (ipergliċemija), żieda fil-melħ, urea, krejatinina u potassium fid- demm tiegħek riżultat tat-test tad-demm li jindika infjammazzjoni (żieda fil-proteina c-reattiva)

secukinumab has been shown to lower (within 1 to 2 weeks of treatment) levels of c-reactive protein, which is a marker of inflammation.
intwera li secukinumab għandu livelli aktar baxxi (fi żmien ġimgħa sa ġimgħatejn ta’ kura) ta’ proteina reattiva c, li huwa indikatur ta’ infjammazzjoni.

the effects of tocilizumab on c-reactive protein (crp), neutrophils and signs and symptoms of infection should be considered when evaluating a patient for a potential infection.
meta pazjent jiġi vvalutat għall-infezzjoni potenzjali, għandhom jiġu kkunsidrati l-effetti ta’ tocilizumab fuq il-proteina Ċ-reattiva (crp), newtrofili u sinjali u sintomi ta’ infezzjoni.

sylvant may mask signs and symptoms of acute inflammation including suppression of fever and of acute-phase reactants, such as c-reactive protein (crp).
sylvant jista’ jaħbi sinjali u sintomi ta’ infjammazzjoni akuta inkluż soppressjoni ta’ deni u ta’ prodotti ta’ reazzjonijiet tal-fażi akuta, bħall-proteina c reattiva (crp - c-reactive protein).

blood pressure increased, electrocardiogram st segment depression, electrocardiogram t wave amplitude decreased, heart rate increased, liver function test abnormal, platelet count decreased, weight increased, semen abnormal, c-reactive protein increased, blood calcium decreased
pressjoni tad- demm aktar għolja, depressjoni fis- segment st fuq l - elektrokardjogramm, tnaqqis fil- wisa 'tat- t wave fuq l - elektrokardjogramm, żieda fir- ritmu tal- qalb, test tal- funzjoni tal- fwied mhux normali, tnaqqis fl- għadd tal- pjastrini, żieda fil- piż, semen abnormali, żieda fil- proteina c- reattiva, tnaqqis tal- kalċju fid- demm

prolonged prothrombin time, prolonged activated partial thromboplastin time, increased international normalised ratio, increased blood alkaline phosphatase, increased blood lactate dehydrogenase, increased c-reactive protein, cytomegalovirus antibody positive
Ħin imtawwal tal- prothrombin, ħin imtawwal tat- thromboplastin parzjali attivat, żieda fl - inr (international normalised ratio), żieda fl- alkaline phosphatase fid - demm, żieda fil- lactate dehydrogenase fid- demm, żieda fis- c- reactive protein, cytomegalovirus antikorp pożittiv

the distribution of the related adrs is as follows: one report of pyrexia and one report of increased c-reactive protein in one subject, one case of urticaria in one subject, one report of pruritus, one report of rash and one report of dizziness in one subject.
it- tqassim ta 'l- adrs relatati huwa kif ġej: rapport wieħed ta' deni u rapport wieħed ta 'proteina Ċ- reattiva akbar f' suġġett wieħed, każ wieħed ta' urtikarja f' suġġett wieħed, rapport wieħed ta 'ħakk rapport wieħed ta' raxx u rapport wieħed ta 'sturdament f' suġġett wieħed.

sepsis* (often called "blood poisoning " is a severe infection with whole-body inflammatory response which can lead to death), increase in certain white blood cells (eosinophilia), low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, somnolence, impaired vision, fast heart beat (tachycardia), dry mouth, upset stomach, taste disturbance (dysgeusia), abnormal liver function (japanese patients are more likely to experience these side effect), rapid swelling of the skin and mucosa which can also lead to death (angioedema also with fatal outcome), eczema (a skin disorder), redness of skin, hives (urticaria), severe drug rash, joint pain (arthralgia), pain in extremity, tendon pain, flu-like-illness, decreased haemoglobin (a blood protein), increased levels of uric acid, increased hepatic enzymes or creatine phosphokinase in the blood.
sepsis* (ta’ spiss imsejħa "avvelenament tad-demm", hi infezzjoni severa b’rispons infjammatorju mal-ġisem kollu li tista’ twassal għal mewt), żieda f’ċerti ċelluli bojod tad-demm (eosinofilija), għadd baxx ta’ plejtlits (tromboċitopenja), reazzjoni allerġika severa (reazzjoni anafilattika), reazzjoni allerġika (eż. raxx, ħakk, diffikultà biex tieħu n-nifs, tħarħir, nefħa tal-wiċċ jew pressjoni tad-demm baxxa), livelli baxxi ta’ zokkor fid-demm (f’pazjenti dijabetiċi, tħossok ansjuż/a, ngħas, indeboliment fil-vista, rata mgħaġġla ta’ taħbit tal-qalb (takikardija), ħalq xott, stonku mqalleb, disturb fit-togħma (tibdil fis-sens tat-togħma), funzjoni anormali tal-fwied (hemm aktar ċans li pazjenti Ġappuniżi jkollhom dawn l-effetti sekondarji), nefħa mgħaġġla tal-ġilda u tal-mukuża li tista wkoll twassal għal mewt (anġjoedema wkoll b’riżultat fatali), ekżema (disturb tal-ġilda), ħmura tal-ġilda, urtikarja (ħorriqija), raxx sever minħabba l-mediċina, uġigħ fil-gogi (artralġja), uġigħ fl-estremitajiet, uġigħ fit- tendini, mard li jixbah l-influwenza, tnaqqis fl-emoglobina (proteina fid-demm), żieda fil-livelli tal- uric acid, żieda fl-enzimi epatiċi jew ta’ creatine phosphokinase fid-demm.